Joint Paris Brain Institute (ICM) – The Neuro Workshop
Joint Paris Brain Institute (ICM) – The Neuro (Montreal Neurological Institute-Hospital) workshop
“Modelling nervous system diseases and disorders using iPSCs”
The Joint Paris Brain Institute (ICM) - The Neuro (Montreal Neurological Institute-Hospital) Workshop is the latest scientific event for this longstanding partnership. Together, we are building a framework to promote and sustain neuroscience research collaborations in fields of mutual strategic interest.
This year’s workshop (program attached) focuses on induced pluripotent stem cell (iPSC)-based modeling in brain disease research. The workshop will address iPSC-based investigations in research areas of mutual interest in the fields of neurodegenerative diseases and neurodevelopmental conditions.
We hope you will join us.
Stefano Stifani
16 December 2020
(All times EST)
8:15-8:30Log-in time
8:35-8:45Welcome and Introduction
Alexis Brice (ICM) and Guy Rouleau (The Neuro)
Session 1: iPSC-based Approaches to study ALS
Chair: Dr. Delphine Bohl (ICM)
8:50-9:05Stefano Stifani (The Neuro)
iPSC-based models of ALS
9:10-9:25Delphine Bohl (ICM)
Co-cultures of IPSC-derived motor neurons, microglia and macrophages to model ALS
Session 2: iPSC-based Approaches to study Parkinson’s Disease
Chair: Dr. Edward Fon (The Neuro)
9:30-9:45Thomas Durcan (The Neuro)
Applying iPSCs into high-content screening modalities
9:50-10:05Philippe Ravassard (ICM)
Assembling 3D region specific organoids to model Alzheimer disease
10:10-10:25Nguyen-Vi Mohammed (The Neuro)
Elevated synuclein level in midbrain organoids drives the formation of synuclein aggregates
10:30-10:45Pause
Session 3: Other iPSC-based Approaches
Chair: Dr. Marie-Claude Potier (ICM)
10:45-11:00Bassem Hassan (ICM)
IPSC-based approaches to study neurodegenerative diseases
11:05-11:20Anouar Khayachi (The Neuro)
Personalized medicine in bipolar disorder: unravelling pathophysiology for improved treatment
11:25-11:40Marie-Claude Potier (ICM)
iPSC-derived endothelial cells to study cerebral amyloid angiopathy in Alzheimer's disease and Down syndrome
11:45-11:55Closing Remarks
Alexis Brice (ICM) and Guy Rouleau (The Neuro)
